Literature DB >> 33926970

Mycobacterium tuberculosis borderline rpoB mutations: emerging from the unknown.

Armand Van Deun1, Tom Decroo2,3, Kya Jai Maug Aung4, Mohamed Anwar Hossain4, Mourad Gumusboga5, Willem Bram De Rijk5, Sabira Tahseen6, Bouke Catherine de Jong5, Leen Rigouts5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33926970     DOI： 10.1183/13993003.00783-2021

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  2 in total

1.  Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment.

Authors: 
Journal:  Eur Respir J       Date:  2022-04-14       Impact factor: 33.795

2.  Ancient and recent differences in the intrinsic susceptibility of Mycobacterium tuberculosis complex to pretomanid.

Authors:  Anna Bateson; Julio Ortiz Canseco; Timothy D McHugh; Adam A Witney; Silke Feuerriegel; Matthias Merker; Thomas A Kohl; Christian Utpatel; Stefan Niemann; Sönke Andres; Katharina Kranzer; Florian P Maurer; Arash Ghodousi; Emanuele Borroni; Daniela Maria Cirillo; Maria Wijkander; Juan C Toro; Ramona Groenheit; Jim Werngren; Diana Machado; Miguel Viveiros; Robin M Warren; Frederick Sirgel; Anzaan Dippenaar; Claudio U Köser; Eugene Sun; Juliano Timm
Journal:  J Antimicrob Chemother       Date:  2022-05-29       Impact factor: 5.758
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.